IDEX Q3 sales rise 10% to $879 mln, beat estimates

IDEX

29/10/2025 11:12

Overview

IDEX Q3 sales rose 10% to $879 mln, beating analyst expectations

Adjusted EPS for Q3 was $2.03, exceeding analyst estimates

Company increased share repurchase authorization to $1 bln

Outlook

IDEX narrows full-year 2025 GAAP EPS to $6.35 - $6.40

Company maintains full-year 2025 organic sales growth at approximately 1%

IDEX expects at least 100% free cash flow conversion for full year 2025

Result Drivers

ACQUISITION IMPACT - Mott acquisition significantly boosted sales, especially in Health & Science Technologies

SEGMENT PERFORMANCE - Higher volumes in Health & Science Technologies and Fluid & Metering Technologies offset by declines in Fire & Safety/Diversified Products

COST CONTAINMENT - Operational productivity improvements and cost containment actions supported results

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Beat
$878.70 mln
$862.27 mln (10 Analysts)
Q3 Adjusted EPS
Beat
$2.03
$1.93 (10 Analysts)
Q3 EPS
$1.70
Q3 Adjusted Net Income
Beat
$152.80 mln
$148.91 mln (6 Analysts)
Q3 Adjusted EBITDA
Beat
$239.80 mln
$208.35 mln (2 Analysts)
Q3 Adjusted Gross Margin
44.50%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

Wall Street's median 12-month price target for IDEX Corp is $197.00, about 15.3% above its October 28 closing price of $166.95

The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release: ID:nBw7Qrqn7a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)